Regulatory20 Jul 2026, 08:30 pm
Bajaj Healthcare: No Deviation in Preferential Issue Proceeds Utilization
AI Summary
Bajaj Healthcare Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. Issued by CARE Ratings Limited, the report confirms nil deviation in the utilization of funds raised through a preferential issue of equity shares and warrants, aggregating to ₹204.97 crore. The report adheres to SEBI regulations and the monitoring agency agreement. The company's promoter is Mr. Sajankumar Rameshwarlal Bajaj, and it operates in the Pharmaceuticals and Biotechnology sector.
Key Highlights
- Monitoring Agency Report confirms nil deviation in fund utilization.
- Funds raised via preferential issue amounted to ₹204.97 crore.
- Report issued by CARE Ratings Limited for Q2 FY27.
- Adheres to SEBI (LODR) Regulations and SEBI (ICDR) Regulations.
Price Impact
More from BAJAJHCARE